K
Koo Foundation Sun Yat-Sen Cancer Center | Department of Chest Medicine
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Avelumab
Platinum
Capecitabine
Pembrolizumab
Temozolomide
Doxorubicin
Cyclophosphamide
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 6 total trials
NBM-BMX is an orally available new chemical entity to inhibit histone deacetylases 8 (HDAC8) activity specifically, being developed as a potential an...
Enrolling
Malignant Neoplasm
Malignant Neoplasm of Brain
Drug: NBM-BMX Capsule
Drug: Temozolomide
Trial sponsors
A
N
O
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems